News

Dr. Sameer Sheth featured in Nature News

02/29/2024

Cain Lab director, Dr. Sameer Sheth, shared his expert opinion on Neuralink's first human brain implant in a news article published by Nature, a leading scientific journal. 

Read the article

More

Katherine Kabotyanski receives top honors from the Society for Neuroscience and Baylor College of Medicine

01/31/2024

Katherine’s research focuses on using real-time brain recordings to inform our basic understanding of complex neurocircuitry and develop novel therapies for neuropsychiatric disorders. She was selected for the above-mentioned awards for her project studying neurobehavioral biomarkers of emotional state.

More

A startup co-founded by Dr. Sheth raises $18M to develop therapeutic brain implants

01/30/2024

Motif Neurotech, a Houston-based startup co-founded by Cain Labs director, Dr. Sameer Sheth along with Rice University faculty and UT Houston physicians has raised $18M to develop a brain implant device to treat treatment-resistant depression and other mental health conditions. 

More

Sheth lab researchers present at leading international conferences

01/02/2024

Several students and trainees mentored by Dr. Sameer Sheth were offered opportunities to present their research at leading international conferences recently.

More

Texas Children’s and Baylor College participate in a multicenter study to evaluate readiness for future STXBP1 disorders clinical trials

12/21/2023

Texas Children’s Hospital and Baylor College of Medicine clinicians and research investigators have recently launched the STXBP1 Clinical Trial Ready (STARR), a new study focused on developing clinical trial readiness for STXBP1-related disorders, an epileptic and neurodevelopmental cond

More